Egret Therapeutics Announces the Addition of Three New Members to its Scientific Advisory Board

NEW YORK, Jan. 3, 2023 /PRNewswire/ — Egret Therapeutics, a clinical-stage company focused on the treatment of neurological diseases, today announced the expansion of its Scientific Advisory Board (SAB) with the appointment of three new members:   E. Sander Connolly Jr., M.D., serves as the Byron Stookey Professor and Chair of the Department of Neurological Surgery at the Vagelos College… Continue reading Egret Therapeutics Announces the Addition of Three New Members to its Scientific Advisory Board